Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplantation for Severe Sickle Cell Disease
NCT00186810Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Dec 1992
- Primary completion
- Feb 2006
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic stem cells in sickle cell disease (SCD), sponsored by St. Jude Children's Research Hospital. Primary endpoints: Engraftment, Graft-Versus-Host Disease and 2 more. Started Dec 1992; status: completed.
02
Drugs
allogeneic stem cells
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00186810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186810.